Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Topographic Expression of IL-1β and Inflammasome-Associated Proteins in Lesional, Perilesional, and Distant Hidradenitis Suppurativa Skin

5 affiliations
  1. 1Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Smoluchowskiego 17 Street, 80-214 Gdansk, Poland
  2. 2Department of Dermatology, Venereology and Allergology, University Clinical Centre in Gdansk, Dębinki 7 Street, 80-952 Gdansk, Poland
  3. 3Department of Medical Chemistry, Medical University of Gdansk, Debinki 1 Street, 80-211 Gdansk, Poland
  4. 4Department of Biophysics, Institute of Biomaterials and Biomolecular Systems, University of Stuttgart, 70569 Stuttgart, Germany
  5. 5Euro-Mediterranean Institute of Science and Technology, 90139 Palermo, Italy

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent nodules, abscesses, draining tunnels, and scarring. Dysregulated IL-1 and inflammasome-associated pathways have been implicated in its pathogenesis, but their spatial distribution beyond clinically apparent lesions remains incompletely characterized. To assess topographic expression of NLRP3, caspase-1, IL-1β, and IL-18 across lesional, perilesional, and distant HS skin. Skin samples were obtained from eight biologic-untreated patients with HS, six patients receiving adalimumab, and five healthy controls. In HS, matched 6 mm full-thickness biopsies were obtained from the same axilla at an active inflammatory lesion (0 cm), clinically normal-appearing skin 2 cm from the visible lesion edge, and clinically uninvolved skin 10 cm from the lesion edge. Protein abundance was assessed by Western blot. Primary topographic effects were evaluated using mixed-design ANOVA with Benjamini–Hochberg FDR correction, supplemented by non-parametric and exploratory contrast analyses. No protein showed an FDR (false discovery rate)-significant overall site effect or cohort × site interaction in the primary analysis. In biologic-untreated HS, IL-18 showed an FDR-significant topographic effect (q = 0.0444), with higher expression at 0 cm than at 10 cm (q = 0.0469). An exploratory post hoc 2-versus-10 cm analysis identified a highly concordant IL-1β pattern: expression was higher at 2 cm in 7/8 biologic-untreated and 6/6 adalimumab-treated patients. Fisher’s combined probability remained significant after BH correction across the four proteins evaluated for this contrast (p = 0.00421, q4 = 0.0168), whereas comprehensive correction across all 12 protein × contrast combinations yielded q12 = 0.0505 and did not meet q < 0.05. Overall, 13/14 patients showed the same direction (92.9%; exact 95% CI 66.1–99.8%). IL-18 provided the clearest FDR-supported secondary topographic finding. IL-1β showed a highly concordant but hypothesis-generating perilesional-to-distant spatial pattern, whereas total NLRP3 and caspase-1 did not show robust FDR-adjusted spatial variation.

Related

  1. Efferocytosis-Related Transcriptional Dysregulation in Hidradenitis Suppurativa Lesional Macrophages: A Multi-Cohort Single-Cell and Bulk Transcriptomic Study
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Male-predominant, perianal-prone hidradenitis suppurativa in China: A cohort study of 614 patients.
    Yanyu Du, Jingwen Zou, Renliang He +1
    JAAD internationalPeer-reviewedCC BYFull text1 citedGeneral medicineEurope PMC
  3. Real-world patient journey and unmet needs of people with hidradenitis suppurativa: Social media research in China.
    John R Ingram, Wen-Yu Wu, Wenbo Bu +4
    JAAD internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Geospatial Associations of Hidradenitis Suppurativa With Structurally Related Airborne Toxins
    Tara McCaffrey, Beita Badiei, Nina Rossa Haddad +8
    JAMA DermatologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  5. Deucravacitinib versus placebo in adults with moderate-to-severe hidradenitis suppurativa: A pilot study.
    Martina L Porter, Maneli Doroudian Tehrani, Nazrin Ashina +7
    JAAD internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{lewandowski2026topographic,
  title = {{Topographic Expression of IL-1β and Inflammasome-Associated Proteins in Lesional, Perilesional, and Distant Hidradenitis Suppurativa Skin}},
  author = {Miłosz Lewandowski and Magdalena Górska-Ponikowska and Anna Jakubczyk-Słabicka and Zuzanna Świerczewska and Wioletta Barańska-Rybak},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = oct,
  doi = {10.3390/ijms27209085},
  url = {https://www.mdpi.com/1422-0067/27/20/9085},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Topographic Expression of IL-1β and Inflammasome-Associated Proteins in Lesional, Perilesional, and Distant Hidradenitis Suppurativa Skin
AU  - Miłosz Lewandowski
AU  - Magdalena Górska-Ponikowska
AU  - Anna Jakubczyk-Słabicka
AU  - Zuzanna Świerczewska
AU  - Wioletta Barańska-Rybak
PY  - 2026
DA  - 2026/10/01
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27209085
UR  - https://www.mdpi.com/1422-0067/27/20/9085
AB  - Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by recurrent nodules, abscesses, draining tunnels, and scarring. Dysregulated IL-1 and inflammasome-associated pathways have been implicated in its pathogenesis, but their spatial distribution beyond clinically apparent lesions remains incompletely characterized. To assess topographic expression of NLRP3, caspase-1, IL-1β, and IL-18 across lesional, perilesional, and distant HS skin. Skin samples were obtained from eight biologic-untreated patients with HS, six patients receiving adalimumab, and five healthy controls. In HS, matched 6 mm full-thickness biopsies were obtained from the same axilla at an active inflammatory lesion (0 cm), clinically normal-appearing skin 2 cm from the visible lesion edge, and clinically uninvolved skin 10 cm from the lesion edge. Protein abundance was assessed by Western blot. Primary topographic effects were evaluated using mixed-design ANOVA with Benjamini–Hochberg FDR correction, supplemented by non-parametric and exploratory contrast analyses. No protein showed an FDR (false discovery rate)-significant overall site effect or cohort × site interaction in the primary analysis. In biologic-untreated HS, IL-18 showed an FDR-significant topographic effect (q = 0.0444), with higher expression at 0 cm than at 10 cm (q = 0.0469). An exploratory post hoc 2-versus-10 cm analysis identified a highly concordant IL-1β pattern: expression was higher at 2 cm in 7/8 biologic-untreated and 6/6 adalimumab-treated patients. Fisher’s combined probability remained significant after BH correction across the four proteins evaluated for this contrast (p = 0.00421, q4 = 0.0168), whereas comprehensive correction across all 12 protein × contrast combinations yielded q12 = 0.0505 and did not meet q < 0.05. Overall, 13/14 patients showed the same direction (92.9%; exact 95% CI 66.1–99.8%). IL-18 provided the clearest FDR-supported secondary topographic finding. IL-1β showed a highly concordant but hypothesis-generating perilesional-to-distant spatial pattern, whereas total NLRP3 and caspase-1 did not show robust FDR-adjusted spatial variation.
SN  - 1422-0067
ER  -